Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Sectors

Powerlist Q&A – Tarik Galijasevic, Allstate Strategic Ventures

Q&A with Tarik Galijasevic, managing director, ASV


Dec 1, 2020

Daily deal net: December 1, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Dec 1, 2020

Investors endow Endomag with $20m

Existing backers including Draper Esprit and Sussex Place Ventures have reinvested to bring Endomag’s overall funding to above $43m.

Dec 1, 2020

Chang Guang charts $375m course

The iFlytek-backed round looks set to be the last for the satellite imaging technology producer before a planned initial public offering.

Dec 1, 2020

Carbice captures $15m series A

Georgia Tech’s heat regulation material developer Carbice picked up capital from Downing Ventures and Toyota AI Ventures that will support recruitment.

Dec 1, 2020

View opens window for reverse merger

SoftBank and Corning-backed dynamic window provider View will go public through a reverse merger at a $1.6bn post-deal valuation.

Dec 1, 2020

Aphea.Bio burrows away $16.8m

Based on Ghent University, KU Leuven and VIB research, Aphea.Bio is now making provisions to launch its initial products.

Dec 1, 2020

Vista Equity Partners gets Gainsight

The customer information software producer has agreed to a majority acquisition at a $1.1bn valuation, having raised $157m from investors including Salesforce and Cisco.

Dec 1, 2020

Tallac Therapeutics tallies up $62m

The immuno-ocology startup has completed a series A round backed by Merck & Co investment vehicle MRL Ventures Fund.

Dec 1, 2020

Facebook to get Kustomer in $1bn acquisition

Cisco Investments will exit the customer management platform developer, which is set to be bought for roughly double its valuation a year ago.

Dec 1, 2020

ServiceNow elects to buy Element AI for $500m

Hanwha, Nvidia, Tencent, Intel, Microsoft and McKinsey & Company are all set to exit the artificial intelligence software developer at a slight dip from its last valuation.

Dec 1, 2020

Xbiome executes series B-plus round

Legend Capital returned as Xbiome secured an eight-digit dollar amount that wil support the progress of its microbiome drug pipeline.

Dec 1, 2020
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here